JP2021516224A5 - - Google Patents

Info

Publication number
JP2021516224A5
JP2021516224A5 JP2020543913A JP2020543913A JP2021516224A5 JP 2021516224 A5 JP2021516224 A5 JP 2021516224A5 JP 2020543913 A JP2020543913 A JP 2020543913A JP 2020543913 A JP2020543913 A JP 2020543913A JP 2021516224 A5 JP2021516224 A5 JP 2021516224A5
Authority
JP
Japan
Prior art keywords
tissue
donor
thymic
recipient
thymus
Prior art date
Application number
JP2020543913A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019165197A5 (https=
JP2021516224A (ja
JP7499178B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/019137 external-priority patent/WO2019165197A1/en
Publication of JP2021516224A publication Critical patent/JP2021516224A/ja
Publication of JP2021516224A5 publication Critical patent/JP2021516224A5/ja
Publication of JPWO2019165197A5 publication Critical patent/JPWO2019165197A5/ja
Priority to JP2024005418A priority Critical patent/JP2024041955A/ja
Application granted granted Critical
Publication of JP7499178B2 publication Critical patent/JP7499178B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543913A 2018-02-23 2019-02-22 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植 Active JP7499178B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024005418A JP2024041955A (ja) 2018-02-23 2024-01-17 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862634377P 2018-02-23 2018-02-23
US62/634,377 2018-02-23
PCT/US2019/019137 WO2019165197A1 (en) 2018-02-23 2019-02-22 Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024005418A Division JP2024041955A (ja) 2018-02-23 2024-01-17 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植

Publications (4)

Publication Number Publication Date
JP2021516224A JP2021516224A (ja) 2021-07-01
JP2021516224A5 true JP2021516224A5 (https=) 2022-01-31
JPWO2019165197A5 JPWO2019165197A5 (https=) 2022-01-31
JP7499178B2 JP7499178B2 (ja) 2024-06-13

Family

ID=67687403

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543913A Active JP7499178B2 (ja) 2018-02-23 2019-02-22 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植
JP2024005418A Pending JP2024041955A (ja) 2018-02-23 2024-01-17 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024005418A Pending JP2024041955A (ja) 2018-02-23 2024-01-17 同種固形臓器移植に対するドナー特異的寛容を促進する培養胸腺組織移植

Country Status (12)

Country Link
US (2) US12064452B2 (https=)
EP (2) EP3755346B1 (https=)
JP (2) JP7499178B2 (https=)
KR (2) KR102805282B1 (https=)
CN (1) CN112074277A (https=)
AU (1) AU2019225151B2 (https=)
BR (1) BR112020016614A2 (https=)
CA (1) CA3089593A1 (https=)
IL (1) IL276706A (https=)
MX (1) MX2020008590A (https=)
SG (1) SG11202007498YA (https=)
WO (1) WO2019165197A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021034650A1 (en) 2019-08-19 2021-02-25 Duke University & Medical Center Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use
CN115287262B (zh) * 2022-01-28 2024-04-02 浙江中医药大学 一种胸腺类器官微球及其制备方法与应用
WO2024042488A1 (en) 2022-08-24 2024-02-29 Enzyvant Therapeutics Gmbh Thymic exosome assays, and methods of producing t cell depleted thymus tissue and uses thereof
WO2025068989A1 (en) 2023-09-29 2025-04-03 Enzyvant Therapeutics Gmbh Device for cultivating and transporting biological tissue
JP7627920B1 (ja) 2023-12-11 2025-02-07 浩 宮内 移植材料の評価方法
CN118203653A (zh) * 2024-02-06 2024-06-18 同济大学 一种利用胸腺疫苗降低或消除同种异体移植排斥的方法
WO2025226936A1 (en) * 2024-04-24 2025-10-30 Revivicor, Inc. Donor-specific tolerance-inducing regimens for xenotransplantation
WO2025240817A1 (en) * 2024-05-17 2025-11-20 The Trustees Of Columbia University In The City Of New York Thymoliver and methods of constructing thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624823A (en) 1991-11-22 1997-04-29 The General Hospital Corporation DNA encoding procine interleukin-10
EP0667792A1 (en) 1991-11-22 1995-08-23 The General Hospital Corporation Specific tolerance in transplantation
ATE215375T1 (de) 1992-01-08 2002-04-15 Gen Hospital Corp Induzierte toleranz gegen transplantate
US5658564A (en) 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US6911220B1 (en) * 1992-02-19 2005-06-28 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5876708A (en) 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5766944A (en) * 1996-12-31 1998-06-16 Ruiz; Margaret Eileen T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
AUPP977899A0 (en) 1999-04-15 1999-05-13 Monash University Improvement of t cell mediated immunity
US20040096971A1 (en) * 2000-12-22 2004-05-20 Blackburn Catherine Clare Thymic epithelial progenitor cells and uses thereof
US20040086508A1 (en) * 2001-06-05 2004-05-06 Advanced Biotherapy, Inc. Treatment of organ transplant rejection
US7037900B2 (en) 2001-10-12 2006-05-02 Supergen, Inc. Composition and method for treating graft-versus-host disease
US7402432B2 (en) * 2003-12-12 2008-07-22 The Brigham And Women's Hospital, Inc. Process for producing T lymphocytes
CA2580271A1 (en) * 2004-10-05 2006-04-20 Genentech, Inc. Method for treating vasculitis
WO2006107601A2 (en) * 2005-04-06 2006-10-12 Duke University Parathyroid and thymus transplantation in digeorge syndrome subjects
EP1993573A2 (en) * 2006-01-13 2008-11-26 Renovar, Inc. Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
US20080131441A1 (en) 2006-09-26 2008-06-05 Manikkam Suthanthiran Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
US9176122B2 (en) 2008-03-24 2015-11-03 University Of South Florida Biomarkers for predicting response to immunosuppressive therapy
JP2013511554A (ja) 2009-11-23 2013-04-04 パラティン テクノロジーズ,インコーポレイテッド メラノコルチン−1受容体特異的線状ペプチド
JP2014503217A (ja) * 2010-12-31 2014-02-13 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク マウスにおける自己t細胞の生成
US8637038B2 (en) * 2011-04-12 2014-01-28 Rigel Pharmaceuticals, Inc. Methods for inhibiting allograft rejection
WO2015056103A2 (en) * 2013-10-15 2015-04-23 Regeneron Pharmaceuticals, Inc. High resolution allele identification
US12090142B2 (en) 2018-02-22 2024-09-17 Board Of Regents, The University Of Texas System Combination therapy for the treatment of cancer
WO2020010067A1 (en) 2018-07-06 2020-01-09 Enzyvant Therapeutics, Inc. Tissue potency determination through quantitative histomorphology analysis

Similar Documents

Publication Publication Date Title
JP2021516224A5 (https=)
DE60302231T2 (de) Transplant-akzeptanz induzierende zellen monocytären ursprungs, sowie deren herstellung und verwendung
JP2024041955A5 (https=)
US6412492B1 (en) Mixed chimerism and tolerance
Meyer et al. Decellularization reduces the immune response to aortic valve allografts in the rat
Cramer et al. Handbook of animal models in transplantation research
JP2016520081A5 (https=)
KR20140144680A (ko) 인간의 망막 전구세포의 표현형 프로필
JPWO2019165197A5 (https=)
JP2002541195A (ja) 移植片に対する免疫寛容を誘導するための、免疫毒素および樹状細胞の成熟を阻害する作用剤を含有する組成物
Evers et al. Stem cells in clinical practice
FR2974369A1 (fr) Amplification de cellules t regulatrices a l'aide d'immunoglobulines anti-thymocytes
JP2020092693A (ja) 免疫抑制作用又は免疫寛容誘導作用を評価する方法、及び免疫寛容誘導剤
KR101694554B1 (ko) 자연살해세포 억제제 및 간엽줄기세포를 유효성분으로 포함하는 이식편대숙주질환의 예방 또는 치료를 위한 세포치료제 조성물
US20070148141A1 (en) Method of using hepatic progenitors in treating liver dysfunction
WO2020121988A1 (ja) 免疫抑制作用又は免疫寛容誘導作用を評価する方法、及び免疫寛容誘導剤
DE60106748T2 (de) Toleranzinduzierendes gewebekonstrukt und organ zusammengesetzt aus thymus und knochenmark
RU2024135671A (ru) Трансплантация культуры ткани тимуса способствует донор-специфической толерантности к аллогенным трансплантатам паренхиматозных органов
Coito et al. The role of cellular and extracellular matrix adhesion proteins in organ transplantation
RU2020124312A (ru) Трансплантация культуры ткани тимуса способствует донор-специфической толерантности к аллогенным трансплантатам паренхиматозных органов
Iske et al. Transplantation of older organs transfers senescence
JPWO2022182763A5 (https=)
Galan et al. Effects of Lymphangiogenesis Blockade On Cell Trafficking, Alloimmunity and Rejection After Skin or Heart Transplantation.: Abstract# B758
KR20230088673A (ko) 연골세포 세포 시트 및 이들의 제조 방법 및 용도
Good Marrow Transplantation and Stem Cell Transplantation in 1996: The Developmental Perspective